Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.
Cerquetti L, Bucci B, Raffa S, Amendola D, Maggio R, Lardo P, Petrangeli E, Torrisi MR, Toscano V, Pugliese G, Stigliano A.
Cerquetti L, et al. Among authors: toscano v.
Front Endocrinol (Lausanne). 2021 May 24;12:667798. doi: 10.3389/fendo.2021.667798. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 34108938
Free PMC article.